Non-cognitive behavior associated with development of Alzheimer pathology in APPswePS1dE9 mice and an effect of long-term paroxetine treatment

Research output: Contribution to conferencePosterResearchpeer-review

Alzheimer’s disease (AD) is a devastating illness characterized by a progressive loss of cognitive, social, and emotional functions, usually starting with memory impairments followed by more global cognitive deficits and neuropsychiatric symptoms. We have used APPswePS1dE9 mice model of AD to characterize non-cognitive behavioral changes associated with development of pathology and differentiated from normal aging. We have used open field and elevated plus maze tests to capture the behavioral pattern of Tg and Wt mice and performed these tests at 9, 12, 15, and 18 months of age. The principal component analysis was used to generalize conclusions based on all behavioral parameters registered during the tests. The long term treatment with the selective serotonin reuptake inhibitor paroxetine (prx) was used to depict the role of 5-HT in the aforementioned behaviour. Alterations in the non-cognitive behavioural phenotype become apparent beyond 15 months of age. We observed decline in locomotion, in exploration and risk assessment behaviour specific for the AD pathology, which were delayed by treatment with prx. Furthermore, the analysis of locomotion at 18 months of age is sufficient to describe the AD associated non-cognitive phenotype.
Original languageEnglish
Publication year5 Nov 2015
Number of pages1
Publication statusPublished - 5 Nov 2015
EventPsykiatriens 10. Forskningsdag: 2015 - Psykiatrisk Hospital i Risskov, Aarhus N, Denmark
Duration: 5 Nov 20155 Nov 2015


ConferencePsykiatriens 10. Forskningsdag
LocationPsykiatrisk Hospital i Risskov
CityAarhus N

    Research areas

  • Alzheimer Disease, mouse model, Behavior

See relations at Aarhus University Citationformats

ID: 94424839